Fortis Advisors’s Medpace MEDP Stock Holding History

Fortis Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-407	Closed	-$30K	–	264
2020 Q1	$30K	Buy	+407	New	+$35.3K	0.02%	208

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fortis Advisors's MEDP Position: Q2 2020 in Review

Fortis Advisors sold out of Medpace (MEDP) in Q2 2020, closing a stake of 407 shares — an estimated $30K sold.

Fortis Advisors first reported a position in MEDP in Q1 2020 and held it in 1 quarter. The position peaked at $30K in Q1 2020. 277 funds tracked by Wall St. Rank hold MEDP as of Q2 2020.

Fortis Advisors reported no remaining Medpace position as of Q2 2020 after selling out during the quarter.
Fortis Advisors sold 407 Medpace shares in Q2 2020, an estimated $30K.
Fortis Advisors first reported a position in Medpace in Q1 2020 and held it in 1 quarter.
Fortis Advisors's Medpace position peaked at $30K in Q1 2020.
277 funds tracked by Wall St. Rank held Medpace as of Q2 2020.

Based on Fortis Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.